- Home
- IZEA vs ALGS Comparison
IZEA vs ALGS Comparison
Compare IZEA & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IZEA | ALGS |
|---|---|---|
| Founded | 2006 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.5M | 43.0M |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IZEA | ALGS |
|---|---|---|
| Price | $3.64 | $7.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $46.67 |
| AVG Volume (30 Days) | ★ 50.0K | 31.3K |
| Earning Date | 01-01-0001 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.30 |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $20,099,695.00 | $2,186,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.91 | N/A |
| P/E Ratio | $50.57 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.68 | $3.76 |
| 52 Week High | $5.86 | $13.69 |
Technical Indicators
Market Signals| Indicator | IZEA | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 49.75 | 55.76 |
| Support Level | $3.48 | $7.61 |
| Resistance Level | $3.92 | $8.84 |
| Average True Range (ATR) | 0.19 | 0.56 |
| MACD | 0.02 | 0.15 |
| Stochastic Oscillator | 43.83 | 77.22 |
Price Performance
Historical ComparisonAbout IZEA IZEA Worldwide Inc.
IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.